News

Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax

The first 4,000 doses have been delivered for use in the Phase II/III clinical trial COV002 by the University of Oxford.

Phase III Trial to Study Combination of Genentech’s Actemra, Gilead’s Remdesivir vs. Severe COVID-19

REMDACTA is expected to start enrolling patients in June, with researchers estimating they will recruit approximately 450 patients…

FDA greenlights ICU AI for predicting fatal COVID-19 complications

FDA greenlights ICU AI for predicting fatal COVID-19 complications

PureTech advances experimental COVID-19 drug into global trials

LYT-100 employs a multimodal mechanism of action to potentially reduce, delay or prevent the lung dysfunction documented in COVID-19 patients

Roche Initiates Phase III Trial in COVID-19 Pneumonia

To evaluate Actemra/RoActemra plus remdesivir in hospitalized patients with severe Pneumonia.

Pregnancy May Reduce Cancer Risk through Epigenetic Reprogramming

Although pregnancy has been linked to a reduced risk of developing breast cancer, a full understanding of the mechanisms involved is still…

Bristol Myers jumps into synthetic lethality with $65M Repare deal

Bristol Myers jumps into synthetic lethality with $65M Repare deal

Researchers develop AI tool able to predict cancer relapse

Researchers are hopeful that this 'ground-breaking approach' could accelerate the prediction of which patients are more at risk of their disease…




Contact Us